12997-1-AP

antibody from Proteintech Group

Targeting: CEBPG GPE1BP, IG/EBP-1

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

12997-1-AP

Provider

Proteintech Group

Product name

CEBPG antibody

Antibody type

Polyclonal

Description

KD/KO validated CEBPG antibody (Cat. #12997-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

RETREG1-mediated reticulophagy is activated by an ATF4-CEBPG/C/EBPγ heterodimer and confers protection against lipotoxicity.

Jin S, Yan M, Liu Y, Zhang S, Song H, Cao C, Li Y, Sun G, Ye L, Chen J, Han W, Li L, Chang Q
Autophagy 2025 Dec;21(12):2614-2632

---

Comprehensive Analysis of CCAAT/Enhancer Binding Protein Family in Ovarian Cancer.

Tan J, Wang D, Dong W, Nian L, Zhang F, Zhao H, Zhang J, Feng Y
Cancer informatics 2024;23:11769351241275877

---

Novel LncRNA LINC02936 Suppresses Ferroptosis and Promotes Tumor Progression by Interacting with SIX1/CP Axis in Endometrial Cancer.

Zhang Z, Li B, Wang Z, Yang L, Peng J, Wang H, Wang Y, Hong L
International journal of biological sciences 2024;20(4):1356-1374

---

l-arginine promotes angio-osteogenesis to enhance oxidative stress-inhibited bone formation by ameliorating mitophagy.

Shen Y, Wang H, Xie H, Zhang J, Ma Q, Wang S, Yuan P, Xue H, Hong H, Fan S, Xu W, Xie Z
Journal of orthopaedic translation 2024 May;46:53-64

---

Single-cell multi-omics analysis reveals candidate therapeutic drugs and key transcription factor specifically for the mesenchymal subtype of glioblastoma.

Yang Y, Liu Z, Wei Y, He S, Gu A, Li Z, Li J, Xu Z, Cen B
Cell & bioscience 2024 Dec 20;14(1):151

---

CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer.

Zhang X, Zheng X, Ying X, Xie W, Yin Y, Wang X
Journal of translational medicine 2023 May 20;21(1):334

---

Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells.

Tian F, Cheng Y, Zhou S, Wang Q, Monavarfeshani A, Gao K, Jiang W, Kawaguchi R, Wang Q, Tang M, Donahue R, Meng H, Zhang Y, Jacobi A, Yan W, Yin J, Cai X, Yang Z, Hegarty S, Stanicka J, Dmitriev P, Taub D, Zhu J, Woolf CJ, Sanes JR, Geschwind DH, He Z
Neuron 2022 Aug 17;110(16):2607-2624.e8

---

CEBPG promotes esophageal squamous cell carcinoma progression by enhancing PI3K-AKT signaling.

Huang Y, Lin L, Shen Z, Li Y, Cao H, Peng L, Qiu Y, Cheng X, Meng M, Lu D, Yin D
American journal of cancer research 2020;10(10):3328-3344

Western blot

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

The CEBPG antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CEBPG. This antibody recognizes human,mouse,rat antigen. The CEBPG antibody has been validated for the following applications: ELISA, WB analysis.

Appendix

12997-1-AP.pdf

Show more

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

MCF-7 cells were subjected to SDS PAGE followed by western blot with 12997-1-AP( CEBPG Antibody) at dilution of 1:300

Other comments

WB

Appendix

12997-1-AP.pdf

Show more